Variation application form and FAQ Variation document updated
M
WHO Prequalification Team – Medicines (PQT/MED) updated the variation application form and FAQ variation document:
PRESENTATIONS NOW AVAILABLE - Joint UNICEF-UNFPA-WHO Meeting with Manufacturers and Suppliers
ID
IVD
IS
M
V
VCP
The 2022 Joint UNICEF-UNFPA-WHO Meeting with Manufacturers and Suppliers took place from 28 November to 1 December 2022 at UN City, Marmorvej 51, 2100 Copenhagen,
HLL Lifecare’s ethinylestradiol/levonorgestrel prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Lupin’s dolutegravir/lamivudine/tenofovir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Newly prequalified Active Pharmaceutical Ingredient (API)
M
Aabcavir (sulfate) (WHOAPI-377) manufactured by Jiangsu Weiqida Pharmaceutical Co Ltd, has been prequalified by the WHO Prequalific